JIN MEDICAL INTERNATIONAL LT (ZJYL) Fundamental Analysis & Valuation

NASDAQ:ZJYL • KYG5140V1124

0.1422 USD
-0.01 (-6.32%)
At close: Mar 10, 2026
0.1422 USD
0 (0%)
Pre-Market: 3/11/2026, 4:02:10 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ZJYL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall ZJYL gets a fundamental rating of 3 out of 10. We evaluated ZJYL against 184 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ZJYL while its profitability can be described as average. ZJYL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. ZJYL Profitability Analysis

1.1 Basic Checks

  • ZJYL had positive earnings in the past year.
  • In the past year ZJYL had a positive cash flow from operations.
  • ZJYL had positive earnings in each of the past 5 years.
  • Of the past 5 years ZJYL 4 years had a positive operating cash flow.
ZJYL Yearly Net Income VS EBIT VS OCF VS FCFZJYL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

  • ZJYL's Return On Assets of 3.69% is fine compared to the rest of the industry. ZJYL outperforms 79.35% of its industry peers.
  • ZJYL has a Return On Equity of 6.42%. This is in the better half of the industry: ZJYL outperforms 78.26% of its industry peers.
  • ZJYL's Return On Invested Capital of 3.84% is fine compared to the rest of the industry. ZJYL outperforms 71.20% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ZJYL is in line with the industry average of 9.15%.
  • The last Return On Invested Capital (3.84%) for ZJYL is well below the 3 year average (9.49%), which needs to be investigated, but indicates that ZJYL had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.69%
ROE 6.42%
ROIC 3.84%
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ZJYL Yearly ROA, ROE, ROICZJYL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • The Profit Margin of ZJYL (7.85%) is better than 79.35% of its industry peers.
  • In the last couple of years the Profit Margin of ZJYL has declined.
  • ZJYL has a Operating Margin of 8.57%. This is in the better half of the industry: ZJYL outperforms 76.63% of its industry peers.
  • ZJYL's Operating Margin has declined in the last couple of years.
  • The Gross Margin of ZJYL (35.79%) is worse than 72.28% of its industry peers.
  • ZJYL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.57%
PM (TTM) 7.85%
GM 35.79%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
ZJYL Yearly Profit, Operating, Gross MarginsZJYL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ZJYL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZJYL is still creating some value.
  • The number of shares outstanding for ZJYL has been increased compared to 1 year ago.
  • ZJYL has less shares outstanding than it did 5 years ago.
  • ZJYL has a worse debt/assets ratio than last year.
ZJYL Yearly Shares OutstandingZJYL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ZJYL Yearly Total Debt VS Total AssetsZJYL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ZJYL has an Altman-Z score of 2.47. This is not the best score and indicates that ZJYL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ZJYL has a Altman-Z score of 2.47. This is in the better half of the industry: ZJYL outperforms 67.93% of its industry peers.
  • ZJYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating ZJYL is somewhat dependend on debt financing.
  • ZJYL's Debt to Equity ratio of 0.56 is on the low side compared to the rest of the industry. ZJYL is outperformed by 60.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 2.47
ROIC/WACC0.46
WACC8.37%
ZJYL Yearly LT Debt VS Equity VS FCFZJYL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • ZJYL has a Current Ratio of 2.11. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ZJYL (2.11) is worse than 60.87% of its industry peers.
  • ZJYL has a Quick Ratio of 1.90. This is a normal value and indicates that ZJYL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.90, ZJYL is in line with its industry, outperforming 49.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.9
ZJYL Yearly Current Assets VS Current LiabilitesZJYL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. ZJYL Growth Analysis

3.1 Past

  • The earnings per share for ZJYL have decreased strongly by -39.04% in the last year.
  • ZJYL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.28% yearly.
  • Looking at the last year, ZJYL shows a quite strong growth in Revenue. The Revenue has grown by 13.42% in the last year.
  • ZJYL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.90% yearly.
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZJYL Yearly Revenue VS EstimatesZJYL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

2

4. ZJYL Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.22, ZJYL is valued correctly.
  • Based on the Price/Earnings ratio, ZJYL is valued cheaper than 86.41% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ZJYL to the average of the S&P500 Index (26.25), we can say ZJYL is valued slightly cheaper.
Industry RankSector Rank
PE 14.22
Fwd PE N/A
ZJYL Price Earnings VS Forward Price EarningsZJYL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -12.94
ZJYL Per share dataZJYL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

  • ZJYL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.34
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZJYL Dividend Analysis

5.1 Amount

  • No dividends for ZJYL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZJYL Fundamentals: All Metrics, Ratios and Statistics

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (3/10/2026, 8:00:03 PM)

Premarket: 0.1422 0 (0%)

0.1422

-0.01 (-6.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.14%
Inst Owner Change79.32%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.26M
Revenue(TTM)22.83M
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.42%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.22
Fwd PE N/A
P/S 0.98
P/FCF N/A
P/OCF 17.06
P/B 0.8
P/tB 0.83
EV/EBITDA -12.94
EPS(TTM)0.01
EY7.03%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY5.86%
SpS0.15
BVpS0.18
TBVpS0.17
PEG (NY)N/A
PEG (5Y)4.34
Graham Number0.2
Profitability
Industry RankSector Rank
ROA 3.69%
ROE 6.42%
ROCE 7.04%
ROIC 3.84%
ROICexc 13.32%
ROICexgc 14.59%
OM 8.57%
PM (TTM) 7.85%
GM 35.79%
FCFM N/A
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ROICexc(3y)22.47%
ROICexc(5y)22.7%
ROICexgc(3y)23.46%
ROICexgc(5y)23.49%
ROCE(3y)12.88%
ROCE(5y)15.84%
ROICexgc growth 3Y-2.39%
ROICexgc growth 5Y-7.19%
ROICexc growth 3Y-4.58%
ROICexc growth 5Y-8.54%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 7.13
Cap/Depr 847.75%
Cap/Sales 9.25%
Interest Coverage 5.51
Cash Conversion 59.19%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.9
Altman-Z 2.47
F-Score4
WACC8.37%
ROIC/WACC0.46
Cap/Depr(3y)178.09%
Cap/Depr(5y)117.95%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y11.4%
EBIT growth 5Y-3.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.18%
OCF growth 3YN/A
OCF growth 5YN/A

JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ

Can you provide the ChartMill fundamental rating for JIN MEDICAL INTERNATIONAL LT?

ChartMill assigns a fundamental rating of 3 / 10 to ZJYL.


What is the valuation status for ZJYL stock?

ChartMill assigns a valuation rating of 2 / 10 to JIN MEDICAL INTERNATIONAL LT (ZJYL). This can be considered as Overvalued.


What is the profitability of ZJYL stock?

JIN MEDICAL INTERNATIONAL LT (ZJYL) has a profitability rating of 6 / 10.


Can you provide the financial health for ZJYL stock?

The financial health rating of JIN MEDICAL INTERNATIONAL LT (ZJYL) is 3 / 10.